Quick Answer
Fortress Biotech, Inc. reported R&D Expense of $83.33 million for fiscal year 2018.
Fortress Biotech, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2018 | $83.33M | +72.5% |
| 2017 | $48.32M | +37.5% |
| 2016 | $35.13M | +17.9% |
| 2015 | $29.81M | +191.1% |
| 2014 | $10.24M | -60.1% |
| 2013 | $25.68M | +47.0% |
| 2012 | $17.47M | +103.5% |
| 2011 | $8.58M | +2.9% |
| 2010 | $8.34M | +267.4% |
| 2009 | $2.27M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| March 31, 2019 | $23.27M | -6.8% | -6.8% |
| March 31, 2018 | $24.96M | +197.0% | +197.0% |
| March 31, 2017 | $8.40M | +8.6% | +14.9% |
| September 30, 2016 | $7.32M | -19.4% | +15.3% |
| June 30, 2016 | $6.35M | +163.3% | -18.0% |
| March 31, 2016 | $7.74M | +371.1% | -14.7% |
| September 30, 2015 | $9.07M | +463.9% | +276.3% |
| June 30, 2015 | $2.41M | +1.4% | +46.8% |
- Fortress Biotech, Inc. showed an increase of +72.5% in R&D Expense compared to the prior fiscal year.
- Over the 2009–2018 period, Fortress Biotech, Inc.’s r&d expense has grown by 3571.1% (from $2.27 million to $83.33 million).
- The most recent figure is from Fortress Biotech, Inc.’s fiscal year 2018 report (Form 10-K), filed with the SEC on March 18, 2019.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: